Drug recalls

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured b…

Amneal Pharmaceuticals of New York, LLC · Defective Delivery System: Possibility of no medication in the prefilled pen.

Class IIOngoingD-0868-2026
Status
Ongoing
City
Brookhaven
State
NY
Country
United States
Classification
Class II
Product type
Drugs
Event ID
99762
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Address 1
50 Horseblock Rd
Postal code
11719-9509
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
USA Nationwide
Recall number
D-0868-2026
Product quantity
5,694 pens
Reason for recall
Defective Delivery System: Possibility of no medication in the prefilled pen.
Recall initiation date
20260828
Center classification date
20260922
Report date
20260930
Code info
Lot #: AP250095A, Exp 2/28/2027
Product description

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Harmonized identifiers (openFDA)
Application number
ANDA206697
Brand name
EXENATIDE
Generic name
EXENATIDE
Manufacturer name
Amneal Pharmaceuticals LLC
Product NDC
70121-1685, 70121-1686
Product type
HUMAN PRESCRIPTION DRUG
Route
SUBCUTANEOUS
Substance name
EXENATIDE
RxCUI
847910, 847915
SPL ID
2141c3ca-074a-4098-85da-1ef78ec4d4dc
SPL set ID
e6cb5c8f-e97f-4a6a-95a4-939fd2393949
Package NDC
70121-1685-1, 70121-1686-1
Is original packager
true
Nui
N0000178480, M0160181, N0000020058
Pharm class epc
GLP-1 Receptor Agonist [EPC]
Pharm class cs
Glucagon-Like Peptide 1 [CS]
Pharm class moa
Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
UNII
9P1872D4OL
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.